Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Chlortalidon, ATC C03BA04

AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseEisenberg, GermanyNot disclosed712 days leftopen

Registrieren zum Speichern Documents (1)

Opportunity Score

Confidence: 70%

Complexity: low

712 days

Deadline

supplies

Contract

Deep Portfolio Analysis

Company fit score
Missing certificates
Eligibility blockers
Bid / No-Bid recommendation

Create account for AI analysis

AI Analysis Summary

Strong opportunity

Open house procedure for non-exclusive discount agreements on Chlortalidon (ATC C03BA04) pharmaceuticals with AOK Rheinland-Pfalz/Saarland. Contracts run max 24 months from August 2026, with no selection process. Any compliant pharmaceutical company can join. Published for transparency, not a public procurement under EU directive.

Strengths

Documents available

Open procedure

Low complexity

Key Requirements

Only pharmaceutical companies are eligible as potential partners
Medicines must be authorized and marketable in Germany (proof via Lauer-Taxe or AMIce database)
Submission of signed contract documents with required evidence of authorization and marketability

Buyer

Name

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse

Location

Eisenberg, DEU

[email protected]

Website

www.aok.de/rheinland-pfalz-saarland/

Buyer profile

Open profile

Identifier

DE271900642

Lots (1)

#LOT-0001Open house Arzneimittelrabattverträge zum Wirkstoff Chlortalidon, ATC C03BA04

Non-exclusive discount agreements for Chlortalidon pharmaceuticals. No selection; all eligible pharma companies can participate. Contracts end by 31.07.2028. First possible start date: 01.08.2026.

33600000DEU